U.K. Biotech, Oxford Immune Algorithmics (OIA) Presents Algocyte at MWC /4YFN Barcelona in the Great Britain & Northern Ireland Pavilion

Oxford Immune Algorithmics (OIA), the creators of Algocyte , and rapid at-home testing for AI-driven immune health monitoring, and AI-driven solution that thinks like a scientist, announced they are exhibiting at MWC/4YFN in Barcelona, February 28th – March 3rd. The award-winning UK-based biotech spin-off from Oxford University says it is proud to be included the Great Britain and Northern Ireland Pavilion.

MWC/4YFN is the world’s most significant connectivity industry event and is attended by global mobile operators, device manufacturers, technology providers, vendors, and content owners. World-leading companies, mobile and tech influencers, and health tech pioneers will engage in thought-leadership discussions on the progression and future of connectivity. Oxford Immune Algorithmics will contribute as AI and immune health monitoring leaders and showcase its AI-driven product Algocyte.

Algocyte will radically change global healthcare, moving it away from its current reliance on population-wide reference values towards a patient-centric approach focused on personalised immune system monitoring. OIA’s AI-driven solution, Algocyte, monitors the immune system using responsible A.I. that reasons like a human medical expert, and is able to explain its decisions, empowering both patients and clinicians.

Oxford Immune Algorithmics (OIA) is an award-winning AI company, incubated by the University of Oxford, that specialises in rapid at-home testing for immune health monitoring.  It uses the best of human and computational intelligence to deliver precise and individualised healthcare to everyone and rid the world of preventable diseases.